Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

S-1: pharmacokinetics of components in rats after single and multiple oral doses

Oct. 16, 1997

Nycomed licenses new anthracycline from Anthra

Oct. 16, 1997

UroCor to copromote Zeneca urology products

Oct. 16, 1997

Schering AG discloses improved taxanes

Oct. 16, 1997

Camptothecin derivatives with potent antitumor activity prepared at P&U

Oct. 16, 1997

Millennium issued U.S. patent for human melanoma gene

Oct. 16, 1997

New immunosuppressive, anticancer compounds from Kyowa Hakko

Oct. 15, 1997

Resistance modulators prepared by Byk Gulden

Oct. 15, 1997

Mayo Clinic to collaborate in developing Dendreon's dendritic cell therapy

Oct. 15, 1997

ONYX-015 combination enters phase II; U.S. patent awarded

Oct. 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...